Click to Share
 
 
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
News By Tag
Small-molecule Remove


April 2015
Mo Su Sa Fr Th We Tu
27 26 25 24 23 22 21

small-molecule Press Releases

  + XML/RSS  



By STATegics, Inc.
STATegics, Inc. announced today that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded the company a second grant to advance its proprietary agonists of the tissue-protective erythropoietin receptor for the treatment of...
By Cambridge Healthtech Institute
Organized by Cambridge Healthtech Institute (CHI) to be held prior to the start of the 14th Annual Structure-Based Drug Design conference.
By Cambridge Healthtech Institute
This event is being held May 22-23, 2014 at the Westin Boston Waterfront, in Boston, Massachusetts
By STATegics, Inc.
STATegics, Inc. announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded the company a grant to advance its proprietary erythropoietin receptor agonist compounds for the treatment of acute kidney...
By STATegics, Inc.
The Michael J. Fox Foundation Awards Grant to Support STATegics’ Preclinical Studies of Small Molecule Erythropoietin Receptor Agonists for the Treatment of Parkinson’s Disease
By STATegics, Inc.
STATegics, Inc. awarded a new grant from the Friedreich’s Ataxia Research Alliance (FARA) to advance erythropoietin receptor agonist compounds for the treatment of Friedreich’s ataxia (FRDA).

All Press Releases

By STATegics, Inc.
STATegics, Inc. announced today that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded the company a second grant to advance its proprietary agonists of the tissue-protective erythropoietin receptor for the treatment of...
By Cambridge Healthtech Institute
Organized by Cambridge Healthtech Institute (CHI) to be held prior to the start of the 14th Annual Structure-Based Drug Design conference.
By Cambridge Healthtech Institute
This event is being held May 22-23, 2014 at the Westin Boston Waterfront, in Boston, Massachusetts
By STATegics, Inc.
STATegics, Inc. announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded the company a grant to advance its proprietary erythropoietin receptor agonist compounds for the treatment of acute kidney...
By STATegics, Inc.
The Michael J. Fox Foundation Awards Grant to Support STATegics’ Preclinical Studies of Small Molecule Erythropoietin Receptor Agonists for the Treatment of Parkinson’s Disease
By STATegics, Inc.
STATegics, Inc. awarded a new grant from the Friedreich’s Ataxia Research Alliance (FARA) to advance erythropoietin receptor agonist compounds for the treatment of Friedreich’s ataxia (FRDA).
By Sarah Brereton, Limewash Media & Design
Isogenica, Biolauncher and Cresset Biomolecular Discovery forge alliance to bring powerful target-to-drugs platform to market. Joint venture aims to rapidly identify small molecule therapeutics to pharma targets.
By KINOMEscan
KINOMEscan™, a leader in kinase profiling services, has just expanded its service offering with the release of scanLIPID™, the largest commercial collection of human lipid kinase assays available.


Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share